Legal & General Group’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $44K | Sell |
4,339
-28,119
| -87% | -$285K | ﹤0.01% | 2737 |
|
|
2025
Q1 | $181K | Sell |
32,458
-470
| -1% | -$2.62K | ﹤0.01% | 2624 |
|
|
2024
Q4 | $266K | Hold |
32,928
| – | – | ﹤0.01% | 2630 |
|
|
2024
Q3 | $338K | Buy |
32,928
+409
| +1% | +$4.19K | ﹤0.01% | 2580 |
|
|
2024
Q2 | $230K | Buy |
32,519
+29,266
| +900% | +$207K | ﹤0.01% | 2649 |
|
|
2024
Q1 | $44.7K | Hold |
3,253
| – | – | ﹤0.01% | 2791 |
|
|
2023
Q4 | $29.9K | Hold |
3,253
| – | – | ﹤0.01% | 2896 |
|
|
2023
Q3 | $19.7K | Sell |
3,253
-501
| -13% | -$3.03K | ﹤0.01% | 3039 |
|
|
2023
Q2 | $29.1K | Buy |
+3,754
| New | +$29.1K | ﹤0.01% | 2968 |
|
|
2022
Q3 | – | Sell |
-2,530
| Closed | -$11K | – | 3475 |
|
|
2022
Q2 | $11K | Sell |
2,530
-7,076
| -74% | -$30.8K | ﹤0.01% | 3365 |
|
|
2022
Q1 | $51K | Hold |
9,606
| – | – | ﹤0.01% | 2999 |
|
|
2021
Q4 | $142K | Buy |
9,606
+560
| +6% | +$8.28K | ﹤0.01% | 2829 |
|
|
2021
Q3 | $189K | Buy |
9,046
+4,889
| +118% | +$102K | ﹤0.01% | 2712 |
|
|
2021
Q2 | $74K | Sell |
4,157
-345
| -8% | -$6.14K | ﹤0.01% | 2826 |
|
|
2021
Q1 | $110K | Buy |
4,502
+1,260
| +39% | +$30.8K | ﹤0.01% | 2592 |
|
|
2020
Q4 | $110K | Buy |
3,242
+2,170
| +202% | +$73.6K | ﹤0.01% | 2562 |
|
|
2020
Q3 | $27K | Sell |
1,072
-340
| -24% | -$8.56K | ﹤0.01% | 2882 |
|
|
2020
Q2 | $47K | Buy |
+1,412
| New | +$47K | ﹤0.01% | 2747 |
|